View All Documents & Correspondence
Ophthalmic Compositions And Methods For The Treatment Of Skin Diseases And Eye Diseases
Abstract: The invention relates to the compounds or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, formula II, formula III and formula IV and the methods for the treatment of eye disorders and skin diseases and may be formulated for the topical eye drop, topical paste, ocular solution, device-drug delivery, oral, buccal, rectal, topical, transdermal, transmucosal, lozenge, spray, intravenous, oral solution, nasal spray, oral solution, cream, dermal ointment, gels, lotions, suspension, oral spray, buccal mucosal layer tablet, parenteral administration, syrup, or injection. Such compositions may be used to treatment of skin diseases and eye diseases.
Notices, Deadlines & Correspondence
Patent Information
Applicants
CELLIX BIO PRIVATE LIMITED
Inventors
1. KANDULA, Mahesh
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202147021049-STATEMENT OF UNDERTAKING (FORM 3) [10-05-2021(online)].pdf | 2021-05-10 |
| 2 | 202147021049-PROOF OF RIGHT [10-05-2021(online)].pdf | 2021-05-10 |
| 3 | 202147021049-PRIORITY DOCUMENTS [10-05-2021(online)].pdf | 2021-05-10 |
| 4 | 202147021049-POWER OF AUTHORITY [10-05-2021(online)].pdf | 2021-05-10 |
| 5 | 202147021049-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105) [10-05-2021(online)].pdf | 2021-05-10 |
| 6 | 202147021049-FORM FOR SMALL ENTITY(FORM-28) [10-05-2021(online)].pdf | 2021-05-10 |
| 7 | 202147021049-FORM 1 [10-05-2021(online)].pdf | 2021-05-10 |
| 8 | 202147021049-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [10-05-2021(online)].pdf | 2021-05-10 |
| 9 | 202147021049-DECLARATION OF INVENTORSHIP (FORM 5) [10-05-2021(online)].pdf | 2021-05-10 |
| 10 | 202147021049-COMPLETE SPECIFICATION [10-05-2021(online)].pdf | 2021-05-10 |
| 11 | 202147021049-Correspondence, Form-1 And POA_08-07-2021.pdf | 2021-07-08 |
| 12 | 202147021049.pdf | 2021-10-18 |
| 13 | 202147021049-FORM 3 [22-10-2021(online)].pdf | 2021-10-22 |
| 14 | 202147021049-FORM 3 [19-04-2022(online)].pdf | 2022-04-19 |
| 15 | 202147021049-FORM 18 [12-10-2022(online)].pdf | 2022-10-12 |
| 16 | 202147021049-FER.pdf | 2022-10-20 |
| 17 | 202147021049-OTHERS [19-04-2023(online)].pdf | 2023-04-19 |
| 18 | 202147021049-FORM-26 [19-04-2023(online)].pdf | 2023-04-19 |
| 19 | 202147021049-FORM 3 [19-04-2023(online)].pdf | 2023-04-19 |
| 20 | 202147021049-FER_SER_REPLY [19-04-2023(online)].pdf | 2023-04-19 |
| 21 | 202147021049-CLAIMS [19-04-2023(online)].pdf | 2023-04-19 |
| 22 | 202147021049-US(14)-HearingNotice-(HearingDate-10-10-2023).pdf | 2023-09-14 |
| 23 | 202147021049-US(14)-ExtendedHearingNotice-(HearingDate-19-10-2023).pdf | 2023-10-10 |
Search Strategy
| 1 | SearchreportE_19-10-2022.pdf |